dys 1 the amount of shares from s&l are not that problem
in response to
by
Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Message: dys 1 the amount of shares from s&l are not that problem
Your Vote:
Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
if the volume increase with huge Quater # like 100mio or more even 80mio are very good inmy eyes.
volume will increase dramatical with this numbers like the old 2006 increase and if s&l realy sell shares at this dicount price i dont think that will be a lot.
i think they dont will the roller coster up and downs befor we see the true # from the j3 or maybe fees for long time so lets ptsc dance and S&L dance with us.
3 Recommendations
Loading...
Loading...
New Message
Please
login
to post a reply